Q2
REGN — Q2 2026 Financial Report Analysis
Regeneron Q2 2026 revenue rose 16.7% to $4.29B and operating profit 19.8% on 38% Dupixent growth, but net income fell 6.8% on lower investment gains and a higher tax rate as original Eylea U.S. sales dropped 45%.